Opportunities & Announcements

All NIAID-relevant grant funding opportunity announcements are listed here. Any amendments to an announcement will be listed in the funding opportunity announcement. For contracts, see NIAID Contract Solicitations. For other funding opportunity resources, see Find a Foundation or Other Funding Source.

Showing results filtered by:
Title Activity Code Posting Date Expiration Date
Genetic Engineering Technologies for HIV Cure Research (U19 Clinical Trial Optional)- RFA-AI-18-058 U19 November 29, 2018 March 12, 2019
Control of Sexually Transmitted Infections (STIs) Through a Comprehensive Understanding of the Natural History of Infection (R01 Clinical Trial Not Allowed)- PA-19-096 R01 November 29, 2018 January 8, 2022
Research to Advance HBV Cure: HIV/HBV Co-Infection and HBV Mono-infection (R01 Clinical Trial Not Allowed)- PAS-19-097 R01 November 29, 2018 January 8, 2022
Accelerating Malaria Vaccine Discovery (R01 Clinical Trial Not Allowed)- PA-19-077 R01 November 26, 2018 January 8, 2022
Advancing Development of Rapid Fungal Diagnostics (R01 Clinical Trial Not Allowed)- PA-19-080 R01 November 26, 2018 January 8, 2022
Advancing Development of Rapid Fungal Diagnostics (R21 Clinical Trial Not Allowed)- PA-19-081 R21 November 26, 2018 January 8, 2022
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R01 Clinical Trial Not Allowed)- PA-19-082 R01 November 26, 2018 January 8, 2022
Novel approaches to understand, prevent, treat, and diagnose coccidioidomycosis (Valley Fever) and other select endemic fungal infections (R21 Clinical Trial Not Allowed)- PA-19-083 R21 November 26, 2018 January 8, 2022
Molecular and Genetic Characterization of Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-19-078 R01 November 26, 2018 January 8, 2022
Molecular and Genetic Characterization of Inborn Errors of Immunity (R21 Clinical Trial Not Allowed)- PAR-19-079 R21 November 26, 2018 January 8, 2022
Long-acting Drug Delivery Systems for ART Optimization in HIV-1 Infected Children (R61/R33 Clinical Trial Not Allowed)- RFA-AI-18-057 R61/R33 November 20, 2018 March 14, 2019
Single-Cell Multi-Omics of HIV Persistence (R01 Clinical Trial Not Allowed)- RFA-AI-18-053 R01 November 13, 2018 March 14, 2019
Processing and Presentation of Non-Conventional MHC Ligands (R21 Clinical Trial Not Allowed)- PA-19-066 R21 November 13, 2018 January 8, 2022
Processing and Presentation of Non-Conventional MHC Ligands (R01 Clinical Trial Not Allowed)- PA-19-067 R01 November 13, 2018 January 8, 2022
Secondary Analysis of Existing Datasets for Advancing Infectious Disease Research (R21 Clinical Trial Not Allowed)- PA-19-068 R21 November 13, 2018 January 8, 2022
NIH Small Research Grant Program (Parent R03 Clinical Trial Not Allowed)- PA-19-052 R03 November 5, 2018 January 8, 2022
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Not Allowed)- PA-19-053 R21 November 5, 2018 January 8, 2022
NIH Exploratory/Developmental Research Grant Program (Parent R21 Clinical Trial Required)- PA-19-054 R21 November 5, 2018 January 8, 2022
Research Project Grant (Parent R01 Clinical Trial Required)- PA-19-055 R01 November 5, 2018 January 8, 2022
Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-19-056 R01 November 5, 2018 January 8, 2022
Engaging Men in HIV Testing, Prevention, and Care (R21 Clinical Trial Optional)- PA-19-050 R21 November 1, 2018 September 8, 2021
Engaging Men in HIV Testing, Prevention, and Care (R01 Clinical Trial Optional)- PA-19-042 R01 November 1, 2018 September 8, 2021
Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01 Clinical Trial Not Allowed)- RFA-CA-19-015 U01 October 31, 2018 February 9, 2019
Limited Competition: Restoring Research Resources Lost or Damaged Due to Hurricanes Harvey, Irma, and Maria (R24 Clinical Trial Optional)- RFA-OD-18-102 R24 October 29, 2018 December 15, 2018
Innovation Corps (I-Corps) at NIH Program for NIH and CDC Translational Research (Admin Supp Clinical Trial Not Allowed)- PA-19-029 Supp October 17, 2018 January 29, 2019
Radiation Biodosimetry Assays and Devices (U01 Clinical Trial Not Allowed)- RFA-AI-18-045 U01 October 10, 2018 February 12, 2019
Fc-Dependent Mechanisms of Antibody-Mediated Killing (U01 Clinical Trial Not Allowed)- RFA-AI-18-042 U01 October 5, 2018 February 2, 2019
Fc-Dependent Mechanisms of Antibody-Mediated Killing (R21 Clinical Trial Not Allowed)- PA-19-020 R21 October 5, 2018 January 8, 2022
Urgent Competitive Revision to Existing NIH Grants and Cooperative Agreements (Urgent Supplement - Clinical Trial Optional)- PA-18-935 Supp October 3, 2018 January 25, 2022
Vaccine and Treatment Evaluation Units (VTEUs) (UM1 Clinical Trial Required)- RFA-AI-18-046 UM1 October 1, 2018 February 16, 2019
Leadership Group for an Infectious Diseases Clinical Research Consortium (IDCRC) (UM1 Clinical Trial Required)- RFA-AI-18-047 UM1 October 1, 2018 February 16, 2019
NIH Administrative Supplements to Recover Losses Due to Hurricanes Harvey, Irma, and Maria Under the Bipartisan Budget Act of 2018 Non-Construction (Admin Supp Clinical Trial Optional)- PA-18-936 Supp September 25, 2018 December 15, 2018
Primary Caregiver Technical Assistance Supplements (PCTAS) (Clinical Trial Optional Admin Supp)- PA-18-926 Supp September 18, 2018 April 2, 2021
Characterization of Mycobacterial Induced Immunity in HIV-infected and Uninfected Individuals (R21 Clinical Trial Not Allowed)- PAR-18-923 R21 September 17, 2018 January 15, 2021
Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed)- PA-18-906 Supp August 22, 2018 September 8, 2021
CNS-Targeted Drug Delivery Strategies for HIV (R01 Clinical Trial Not Allowed) - PAR-18-895 R01 August 8, 2018 January 8, 2021
Expanding Extramural Research Opportunities at the NIH Clinical Center (U01 Clinical Trial Optional)- PAR-18-879 U01 July 26, 2018 December 4, 2020
HIV Drug Resistance: Genotype-Phenotype-Outcome Correlations (R01 Clinical Trial Not Allowed)- RFA-AI-18-029 R01 July 24, 2018 December 6, 2018
Research to Advance Vaccine Safety (R21 Clinical Trial Not Allowed)- PA-18-872 R21 July 24, 2018 September 8, 2021
Research to Advance Vaccine Safety (R01 Clinical Trial Not Allowed)- PA-18-873 R01 July 24, 2018 September 8, 2021
Immune Response to Arthropod Blood Feeding (R21 Clinical Trial Not Allowed)- PAR-18-860 R21 July 19, 2018 October 16, 2020
Advancing Research Needed to Develop a Universal Influenza Vaccine (R21 Clinical Trial Not Allowed)- PA-18-858 R21 July 18, 2018 September 8, 2021
Advancing Research Needed to Develop a Universal Influenza Vaccine (R01 Clinical Trial Not Allowed)- PA-18-859 R01 July 18, 2018 September 8, 2021
Leadership Group for a Clinical Research Network on Antibacterial Resistance (UM1 Clinical Trial Required)- RFA-AI-18-036 UM1 July 9, 2018 January 4, 2019
Halting TB Transmission in HIV-Endemic and Other High-Transmission Settings (R01 Clinical Trial Not Allowed)- RFA-AI-18-037 R01 July 3, 2018 December 6, 2018
Advancing mAbs to Achieve a Drug-free Sustained HIV Virologic Remission (U01 Clinical Trial Required)- RFA-AI-18-022 U01 June 28, 2018 October 10, 2019
Global Infectious Disease Research Training Program (D43 Clinical Trial Optional)- PAR-18-840 D43 June 26, 2018 July 26, 2019
Administrative Supplements to Promote Diversity in Small Businesses-SBIR/STTR (Admin Supp Clinical Trial Not Allowed)- PA-18-837 Supp June 20, 2018 September 5, 2021
Modeling and Simulation to Optimize HIV Prevention Research (MS OPR) (R01 Clinical Trial not allowed)- RFA-AI-18-026 R01 June 19, 2018 December 14, 2018
Approaches for Understanding Disease Mechanisms and Improving Outcomes in TB Meningitis (TBM) (R01 Clinical Trial Not Allowed)- PAR-18-822 R01 June 7, 2018 September 5, 2020
Administrative Supplements for Research on Dietary Supplements (Admin Supp - Clinical Trial Not Allowed)- PA-18-817 Supp June 5, 2018 April 16, 2020
Collaborative Cross (CC) Mouse Model Generation and Discovery of Immunoregulatory Mechanisms (R21 Clinical Trials Not Allowed)- PAR-18-781 R21 May 11, 2018 September 10, 2020
Harnessing Big Data to Halt HIV (R01 Clinical Trial Optional)- PAR-18-764 R01 April 20, 2018 May 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R01 Clinical Trial Optional)- PA-18-753 R01 April 11, 2018 May 8, 2021
Novel Biomarkers for the Development of HIV Incidence Assays with Improved Specificity (R21 Clinical Trial Not Allowed)- PA-18-754 R21 April 11, 2018 May 8, 2021
Mechanisms Underlying the Contribution of Type 1 Diabetes Disease-Associated Variants (R01 Clinical Trial Not Allowed)- RFA-DK-18-005 R01 April 3, 2018 December 7, 2018
Research on the Health of Transgender and Gender Nonconforming Populations (R21 Clinical Trial Optional)- PA-18-728 R21 March 28, 2018 January 8, 2021
Research on the Health of Transgender and Gender Nonconforming Populations (R01 Clinical Trial Optional)- PA-18-729 R01 March 28, 2018 January 8, 2021
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R01 Clinical Trial Optional)- PA-18-722 R01 March 28, 2018 May 8, 2021
Improving Patient Adherence to Treatment and Prevention Regimens to Promote Health (R21 Clinical Trial Optional)- PA-18-723 R21 March 28, 2018 May 8, 2021
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R21 Clinical Trial Not Allowed) - PA-18-724 R21 March 28, 2018 May 8, 2021
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01 Clinical Trial Not Allowed)- PA-18-725 R01 March 28, 2018 May 8, 2021
Investigations on Primary Immunodeficiency Diseases/Inborn Errors of Immunity (R01 Clinical Trial Not Allowed)- PAR-18-712 R01 March 15, 2018 May 8, 2021
Academic Research Enhancement Award for Undergraduate-Focused Institutions (R15 Clinical Trial Not Allowed)- PAR-18-714 R15 March 14, 2018 May 8, 2021
NIAID Physician-Scientist Pathway to Independence Award (K99/R00 Clinical Trial Required)- PAR-18-679 K99/R00 February 23, 2018 May 8, 2020
Ruth L. Kirschstein National Research Service Award (NRSA)Individual Fellowship for Students at Institutions Without NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-18-673 F30 February 20, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31)- PA-18-671 F31 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Fellowship for Students at Institutions with NIH-Funded Institutional Predoctoral Dual-Degree Training Programs (Parent F30)- PA-18-668 F30 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Postdoctoral Fellowship (Parent F32)- PA-18-670 F32 February 16, 2018 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship to Promote Diversity in Health-Related Research (Parent F31)- PA-18-666 F31 February 15, 2018 January 8, 2021
Immune System Engineering For Targeted Tolerance in Type 1 Diabetes (R01 Clinical Trial Not Allowed)- RFA-DK-17-020 R01 February 14, 2018 December 7, 2018
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R01 Clinical Trial Optional)- PA-18-651 R01 February 12, 2018 January 8, 2021
Developmentally Tailored HIV Prevention and Care Research for Adolescents and Young Adults (R21 Clinical Trial Not Allowed)- PA-18-652 R21 February 12, 2018 January 8, 2021
NIH Support for Conferences and Scientific Meetings (Parent R13 Clinical Trial Not Allowed)- PA-18-648 R13 February 9, 2018 January 8, 2021
NIAID SBIR Phase II Clinical Trial Implementation Cooperative Agreement (U44 Clinical Trial Required)- PAR-18-632 U44 February 6, 2018 January 14, 2021
NIAID Clinical Trial Implementation Cooperative Agreement (U01 Clinical Trial Required)- PAR-18-633 U01 February 6, 2018 January 14, 2021
Investigator Initiated Extended Clinical Trial (R01 Clinical Trial Required)- PAR-18-630 R01 February 5, 2018 December 7, 2019
Change of Grantee Organization (Type 7 Parent Clinical Trial Optional)- PA-18-590 January 26, 2018 January 26, 2021
Successor-in-Interest (Type 6 Parent Clinical Trial Optional)- PA-18-589 January 26, 2018 January 26, 2021
Administrative Supplements to Existing NIH Grants and Cooperative Agreements (Parent Admin Supp - Clinical Trial Optional)- PA-18-591 Supp January 25, 2018 January 26, 2021
Research Supplements to Promote Re-Entry into Biomedical and Behavioral Research Careers (Admin Supp - Clinical Trial Not Allowed )- PA-18-592 Supp January 25, 2018 September 8, 2021
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44] Clinical Trial Not Allowed)- PA-18-574 R43/R44 January 16, 2018 April 6, 2019
PHS 2018-02 Omnibus Solicitation of the NIH, CDC, and FDA for Small Business Technology Transfer Grant Applications (Parent STTR [R41/R42] Clinical Trial Not Allowed)- PA-18-575 R41/R42 January 16, 2018 April 6, 2019
Radiological/Nuclear Medical Countermeasure Product Development Program (SBIR) (R43/R44 Clinical Trial Not Allowed)- PA-18-525 R43/R44 December 19, 2017 January 6, 2021
Academic Research Enhancement Award (Parent R15 Clinical Trial Not Allowed)- PA-18-504 R15 December 13, 2017 January 8, 2021
NIH Exploratory/Developmental Research Grant Program ( Parent R21 Clinical Trial Not Allowed)- PA-18-489 R21 December 6, 2017 January 8, 2019
NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed)- PA-18-484 R01 December 6, 2017 January 8, 2019
NIH Pathway to Independence Award (Parent K99/R00 - Independent Clinical Trial Not Allowed)- PA-18-398 K99/R00 November 29, 2017 January 8, 2021
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - Clinical Trial Required)- PA-18-393 K24 November 22, 2017 January 8, 2021
Midcareer Investigator Award in Patient-Oriented Research (Parent K24 - No Independent Clinical Trials)- PA-18-394 K24 November 22, 2017 January 8, 2021
Mentored Quantitative Research Development Award (Parent K25 - No Independent Clinical Trials)- PA-18-396 K25 November 22, 2017 January 8, 2021
Mentored Clinical Scientist Research Career Development Award (Parent K08 - No Independent Clinical Trials)- PA-18-373 K08 November 21, 2017 January 8, 2021
Mentored Patient-Oriented Research Career Development Award (Parent K23 - Independent Clinical Trials Not Allowed)- PA-18-375 K23 November 21, 2017 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant (Parent T32)- PA-18-403 T32 November 21, 2017 January 8, 2021
Ruth L. Kirschstein National Research Service Award (NRSA) Short-Term Institutional Research Training Grant (Parent T35)- PA-18-404 T35 November 21, 2017 January 8, 2021
Mentored Research Scientist Development Award (Parent K01 -Independent Clinical Trial Not Allowed)- PA-18-369 K01 November 20, 2017 January 8, 2021
Getting to Zero: Understanding HIV Viral Suppression and Transmission in the United States (R01 Clinical Trial Not Allowed)- PAR-18-411 R01 November 16, 2017 March 14, 2020
Trophoblast Differentiation and Function (R21 Clinical Trial Optional)- PA-18-047 R21 November 15, 2017 January 8, 2020
Zika Virus (ZIKV) Complications (R21 Clinical Trial Optional)- PA-18-048 R21 November 15, 2017 January 8, 2020
Bioengineering Research Grants (BRG) (R01 Clinical Trial Optional)- PAR-18-206 R01 November 7, 2017 May 8, 2019
NIH Research Project Grant (Parent R01 Clinical Trial Required)- PA-18-345 R01 November 3, 2017 January 8, 2019
Dissemination and Implementation Research in Health (R01 Clinical Trial Optional)- PAR-18-007 R01 November 3, 2017 May 8, 2019
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional)- PAR-18-017 R21 November 3, 2017 May 8, 2019
Global Infectious Disease Research Administration Development Award for Low- and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed)- PAR-18-335 G11 October 31, 2017 August 1, 2020
Understanding the Early Development of the Immune System (R01 - Clinical Trial Not Allowed)- PAR-18-333 R01 October 25, 2017 December 6, 2019
HIV Vaccine Research and Design (HIVRAD) Program (P01 Clinical Trial Not Allowed)- PAR-18-319 P01 October 13, 2017 March 14, 2020
Research on Transgender Health (R21) - PA-17-477 R21 September 8, 2017 January 8, 2021
Research on Transgender Health (R01)- PA-17-478 R01 September 8, 2017 January 8, 2021
Detection of HIV for Self-Testing (R61/R33)- PAR-17-471 R61/R33 August 25, 2017 December 7, 2019
Stimulating Access to Research in Residency (StARR) (R38)- RFA-HL-18-023 R38 August 23, 2017 May 13, 2020
NIAID Research Education Program (R25)- PAR-17-455 R25 August 11, 2017 December 6, 2019
Ethical, Legal, and Social Implications (ELSI) of Genomics Exploratory/Developmental Research Grant Program (R21)- PA-17-446 R21 August 1, 2017 September 8, 2020
Ethical, Legal, and Social Implications (ELSI) of Genomics Small Research Grant Program (R03)- PA-17-445 R03 August 1, 2017 September 8, 2020
Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03) - PAR-17-439 R03 July 28, 2017 September 8, 2020
Assay development and screening for discovery of chemical probes or therapeutic agents (R01)- PAR-17-438 R01 July 27, 2017 September 8, 2020
Small Grants on Primary Immunodeficiency Diseases (R03)- PAR-17-332 R03 July 21, 2017 July 17, 2019
Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21)- PAR-17-333 R21 July 21, 2017 July 17, 2019
NIAID Physician-Scientist Pathway to Independence Award (K99/R00)- PAR-17-329 K99/R00 July 20, 2017 May 8, 2020
Optimizing HIV Phylodynamics to Target and Interrogate Clusters (OPTICs) (R21)- PA-17-306 R21 June 7, 2017 May 8, 2020
Imaging the Persistent HIV Reservoir (R01)- PA-17-305 R01 June 6, 2017 May 8, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R21)- PA-17-278 R21 May 12, 2017 May 8, 2020
HIV and Hepatitis B Co-Infection: Advancing HBV Functional Cure through Clinical Research (R01)- PA-17-279 R01 May 12, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R01)- PA-17-280 R01 May 12, 2017 May 8, 2020
In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)- PA-17-281 R21 May 12, 2017 May 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)- PA-17-282 R21 May 12, 2017 September 8, 2020
Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)- PA-17-283 R01 May 12, 2017 September 8, 2020
Modeling of Infectious Disease Agent Study Research Projects (R01)- PAR-17-267 R01 May 5, 2017 May 8, 2019
Innovation for HIV Vaccine Discovery (R01)- PAR-17-263 R01 April 25, 2017 August 2, 2019
Centers for AIDS Research (P30)- PAR-17-237 P30 March 30, 2017 August 18, 2019
Developmental Centers for AIDS Research (P30)- PAR-17-238 P30 March 30, 2017 August 18, 2019
International Research in Infectious Diseases, including AIDS (R01) - PAR-17-142 R01 January 27, 2017 August 23, 2019
NK Cells to Induce Immunological Memory to Prevent HIV Infection (R01)- PA-17-114 R01 January 9, 2017 January 8, 2020
Fc Receptor (FcR) and Antibody Effector Function in HIV Vaccine Discovery (R01)- PA-17-113 R01 January 9, 2017 January 8, 2020
HIV-1 Infection of the Central Nervous System (R01)- PA-17-100 R01 January 5, 2017 January 8, 2020
Eradication of HIV-1 From Central Nervous System Reservoirs (R01)- PA-17-084 R01 December 13, 2016 January 8, 2020
Platform Delivery Technologies for Nucleic Acid Therapeutics (R43/R44)- PAR-17-035 R43/R44 October 27, 2016 September 6, 2019
Platform Delivery Technologies for Nucleic Acid Therapeutics (R41/R42)- PAR-17-036 R41/R42 October 27, 2016 September 6, 2019
Trophoblast Differentiation and Function (R01)- PA-16-445 R01 September 23, 2016 January 8, 2020
Support of Competitive Research (SCORE) Research Advancement Award - PAR-16-439 SC1 September 21, 2016 September 8, 2019
Support of Competitive Research (SCORE) Pilot Project Award- PAR-16-438 SC2 September 21, 2016 September 8, 2019
NIAID Career Transition Award- PAR-16-434 K22 September 16, 2016 September 8, 2019
NIAID Resource-Related Research Projects- PAR-16-412 R24 August 18, 2016 September 8, 2019
NIAID Investigator-Initiated Program Project Applications- PAR-16-413 P01 August 18, 2016 September 8, 2019
Serious Adverse Drug Reaction Research (R21)- PAR-16-274 R21 May 19, 2016 September 8, 2019
Serious Adverse Drug Reaction Research (R01)- PAR-16-275 R01 May 19, 2016 September 8, 2019
NIAID Clinical Trial Planning Grant- PAR-16-272 R34 May 18, 2016 May 14, 2019
Sustained Release of Antivirals for Treatment or Prevention of HIV (SRATP)- PAR-16-262 R01 May 17, 2016 January 5, 2019
Mechanisms of Mycobacterial-Induced Immunity in HIV-Infected and Uninfected Individuals to Inform Innovative Tuberculosis Vaccine Design- PAR-16-254 R01 May 11, 2016 January 12, 2019
Dissemination and Implementation Research in Health (R01)- PAR-16-238 R01 May 10, 2016 May 8, 2019
Dissemination and Implementation Research in Health (R21)- PAR-16-236 R21 May 10, 2016 May 8, 2019
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R01)- PA-16-243 R01 May 9, 2016 September 8, 2019
Novel Approaches to Understanding, Preventing, and Treating Lyme Disease and Tickborne Coinfections (R21)- PA-16-244 R21 May 9, 2016 September 8, 2019
The Use of mRNA for an HIV Envelope Vaccine (R43/R44)- PA-16-207 R43/R44 April 19, 2016 April 6, 2019
The Use of mRNA for an HIV Envelope Vaccine (R41/R42)- PA-16-208 R41/R42 April 19, 2016 April 6, 2019
Tools for Cell Line Identification- PA-16-186 R43/R44 April 15, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R41/R42)- PA-16-182 R41/R42 April 12, 2016 April 6, 2019
Strategies for the Improvement of HIV Envelope Protein Expression and Yield (R43/R44)- PA-16-184 R43/R44 April 12, 2016 April 6, 2019
Indo-U.S. Vaccine Action Program (VAP) Small Research Grant Program (R03)- PA-16-163 R03 April 4, 2016 May 8, 2019
Optimization of Monoclonal Antibodies for Eliminating the HIV Reservoir- PAR-16-115 R01 February 25, 2016 January 10, 2019
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R01)- PAR-16-093 R01 February 9, 2016 May 8, 2019
Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R21)- PAR-16-094 R21 February 9, 2016 May 8, 2019